YILING
以岭药业
The Shijiazhuang Yiling Pharmaceutical Co., Ltd., a key high-tech enterprise in China, was founded by Academician Wu Yiling of the Chinese Academy of Engineering. Under his leadership, Yiling Pharmaceutical has always adhered to a technology-led, market-driven innovative development strategy. The company established a unique operational model integrating “Theory – Clinical Practice – Scientific Research – Industry – Teaching”, and built a new drug R&D innovation system guided by the theory of Traditional Chinese Medicine (TCM) meridian pathology. National leaders from the Ministry of Science and Technology have praised the five-in-one development model as a “pioneering achievement in the industrialization of TCM scientific and technological results in China.”
Throughout the development journey of Yiling Pharmaceutical, the company has amassed a vast team of experts in research, production, management, and marketing, including returning experts from abroad, foreign experts, PhDs, masters, and other high-level professionals. The company has become the base for post-doctoral research stations under the National Human Resources Department, and PhD and Master’s student training centers at Hebei Medical University. The company has manufacturing bases in Shijiazhuang (Hebei), Daxing (Beijing), Miyun, and other locations, ensuring product supply. They have introduced advanced equipment and pharmaceutical processes from both domestic and foreign sources to establish a comprehensive quality control system that meets international standards.
Yiling Pharmaceutical has driven the industrialization of TCM through innovative meridian pathology theory, using modern high-tech methods to research and develop traditional Chinese medicines, western medicines, and biopharmaceuticals. They have developed over 10 patented new drugs and have won numerous awards, including the National Science and Technology Progress Award. The company’s product line includes treatments for cardiovascular diseases, respiratory diseases, tumors, diabetes, and other significant illnesses. They possess TCM production lines certified by the National GMP and chemical preparations workshops certified by the European Union. Yiling Pharmaceutical ranks among the top 20 listed pharmaceutical companies in China.
Yiling Pharmaceutical, a company engaged in the R&D of traditional Chinese medicine, western medicine, and biomedicine using modern high-tech techniques, has core products like Lianhua Qingwen, a renowned brand for treating colds. Other notable products include cardiovascular oral preparations like Tongxinluo, Shensong Yangxin, and Qili Qiangxin capsules. The company covers a range of diseases, from cardiovascular and respiratory to tumors and diabetes.
Shijiazhuang Yiling Pharmaceutical Co., Ltd. was established on June 16, 1992 (stock code 002603). The company’s mission is “To inherit, innovate, and benefit humanity”, with a development goal of “Technology for a healthier tomorrow”. Their business philosophy emphasizes employee growth, social contribution, and shareholder value creation. The company has consistently pursued an innovative development strategy, focusing on technology and market demand. They have systemically built the meridian pathology theory system, forming an industrial development cluster from “medicine to drugs to health.” Their “TCM Meridian Disease Diagnosis and Treatment Methods” have been included in the national intangible cultural heritage, and their “Meridian Disease Study” has become a university textbook, taught in over 40 universities nationwide. They have undertaken numerous national and provincial projects.
The company has developed and researched over 10 patented new medicines, like Tongxinluo capsules for coronary heart disease and cerebral infarction, Shensong Yangxin capsules for arrhythmias, Qili Qiangxin capsules for chronic heart failure, and Lianhua Qingwen capsules for colds and flu, among others. They have obtained over 800 patents. The company has established over 30 raw material bases for Chinese medicinal herbs in China. Their production workshops have passed international certifications from the US, European Union, Canada, New Zealand, and other countries and regions. Lianhua Qingwen has been marketed in over 30 countries.
Best-selling Products from the YILING Brand：
